Login
E-mail
Password
Mostra password
Ricorda
Password dimenticata?
Iscriviti gratuitamente
Registrazione
Registrazione
Parametri
Parametri
Quotazioni dinamiche 
OFFON

ODONATE THERAPEUTICS, INC.

(ODTC)
RiassuntoQuotazioniGraficiNotizieRatingAgendaSocietąFinanzaConsensusDerivati 
RiassuntoTutte le notizieAltre lingueComunicati stampaPubblicazioni ufficialiNotizie del settore
Notizie in altre lingue su ODONATE THERAPEUTICS, INC.
20/01ODONATE THERAPEUTICS, INC.(NASDAQGS: ODT) dropped from S&P Global BMI Index
20/01ODONATE THERAPEUTICS, INC.(NASDAQGS: ODT) dropped from S&P TMI Index
17/01ODONATE THERAPEUTICS, INC.(NASDAQGS: ODT) dropped from NASDAQ Composite Index
07/01Top Midday Decliners
07/01Odonate Therapeutics Gets Nasdaq Notice to Delist Shares
07/01ODONATE THERAPEUTICS: Delisting/Failure to Satisfy Listing Rule/Transfer of Listing - For..
07/01ODONATE THERAPEUTICS, INC.: Notice of Delisting or Failure to Satisfy a Continued Listing..
07/01Odonate Announces Expected Delisting of Its Stock
2021ODONATE THERAPEUTICS, INC.(NASDAQGS: ODT) dropped from NASDAQ Biotechnology Index
2021INSIDER SELL: Odonate Therapeutics
2021ODONATE THERAPEUTICS: Announces Planned Return of Capital to Stockholders through Share R..
2021ODONATE THERAPEUTICS, INC.: Other Events, Financial Statements and Exhibits (form 8-K)
2021Odonate Therapeutics Plans Share Buybacks After Halting Development of Breast Cancer Dr..
2021Odonate Therapeutics Announces Planned Return of Capital to Stockholders through Share ..
2021Odonate Therapeutics, Inc. announces an Equity Buyback for 20,000,000 shares, represent..
2021Odonate Therapeutics, Inc. authorizes a Buyback Plan.
2021Odonate Therapeutics Announces Financial Results for the Three and Nine Months Ended Se..
2021ODONATE THERAPEUTICS, INC. Management's Discussion and Analysis of Financial Condition..
2021Odonate Therapeutics, Inc. Reports Earnings Results for the Third Quarter and Nine Mont..
2021NORTH AMERICAN MORNING BRIEFING: Stock Futures -3-
2021SHAREHOLDER ALERT: Odonate Therapeutics, Inc. (ODT) Officers and Directors Under Investig..
2021THE LAW OFFICES OF FRANK R. CRUZ: Announces Investigation of Odonate Therapeutics, Inc. (..
2021ODONATE THERAPEUTICS, INC.: Change in Directors or Principal Officers, Financial Statemen..
2021Odonate Therapeutics, Inc. Announces Termination of Joseph O’Connell as Chief Medical O..
2021ODONATE THERAPEUTICS: Announces Financial Results for the Three and Six Months Ended June..
2021ODONATE THERAPEUTICS: Management's Discussion and Analysis of Financial Condition and Res..
2021Odonate Therapeutics, Inc. Reports Earnings Results for the Second Quarter Ended June 3..
2021ODONATE THERAPEUTICS, INC.: Submission of Matters to a Vote of Security Holders, Financia..
2021ODONATE THERAPEUTICS, INC.(NASDAQGS: ODT) dropped from Russell Small Cap Completeness Ind..
2021ODONATE THERAPEUTICS, INC.(NASDAQGS: ODT) dropped from Russell 3000 Index
2021ODONATE THERAPEUTICS, INC.(NASDAQGS: ODT) dropped from Russell 3000E Growth Index
2021ODONATE THERAPEUTICS, INC.(NASDAQGS: ODT) added to Russell Microcap Value Index
2021ODONATE THERAPEUTICS, INC.(NASDAQGS: ODT) dropped from Russell 2000 Dynamic Index
2021ODONATE THERAPEUTICS, INC.(NASDAQGS: ODT) dropped from Russell 2000 Index
2021ODONATE THERAPEUTICS, INC.(NASDAQGS: ODT) added to Russell 3000E Value Index
2021ODONATE THERAPEUTICS, INC.(NASDAQGS: ODT) added to Russell Microcap Index
2021ODONATE THERAPEUTICS, INC.(NASDAQGS: ODT) dropped from Russell 2500 Growth Index
2021ODONATE THERAPEUTICS, INC.(NASDAQGS: ODT) dropped from Russell 3000 Growth Index
2021ODONATE THERAPEUTICS, INC.(NASDAQGS: ODT) dropped from Russell Small Cap Comp Growth Inde..
2021ODONATE THERAPEUTICS, INC.(NASDAQGS: ODT) dropped from Russell 2000 Growth Index
2021ODONATE THERAPEUTICS, INC.(NASDAQGS: ODT) dropped from Russell 2500 Index
2021ODONATE THERAPEUTICS, INC.(NASDAQGS: ODT) dropped from S&P Pharmaceuticals Select Industr..
2021ODONATE THERAPEUTICS: Announces Financial Results for the Three Months Ended March 31, 20..
2021ODONATE THERAPEUTICS: Management's Discussion and Analysis of Financial Condition and Res..
2021Odonate Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 3..
2021ODONATE THERAPEUTICS: Stock Slumps on Plans to Scrap Cancer Drug Tesetaxel Development
2021MIDDAY REPORT: Wall Street Rises Midday as Data Cool Inflation Worries
2021ODONATE THERAPEUTICS, INC.: Costs Associated with Exit or Disposal Activities, Financial ..
2021SECTOR UPDATE: Health Care Stocks Rising Just Ahead of Monday Close
2021SECTOR UPDATE: Health Care Stocks Posting Modest Gains
2021ODONATE THERAPEUTICS: to Discontinue Development of Tesetaxel for Cancer; Shares Plunge
2021ODONATE THERAPEUTICS: Announces Discontinuation of Development of Tesetaxel
2021Odonate Therapeutics Announces Discontinuation of Development of Tesetaxel
2021ODONATE THERAPEUTICS, INC.(NASDAQGS: ODT) added to S&P Pharmaceuticals Select Industry In..
2021ODONATE THERAPEUTICS: Corporate Presentation March 2021
2021ODONATE THERAPEUTICS: Posts Narrower Q4 Loss
2021ODONATE THERAPEUTICS: Announces Financial Results for the Three and Twelve Months Ended D..
2021ODONATE THERAPEUTICS, INC.: Entry into a Material Definitive Agreement, Financial Stateme..
2021ODONATE THERAPEUTICS: Management's Discussion and Analysis of Financial Condition and Res..
2021ODONATE THERAPEUTICS: Insiders Make Significant Stock Buys in Odonate Therapeutics (ODT) ..
2020INSIDER TRENDS: Insider Buying Added to with Purchase of Odonate Therapeutics Shares
2020INSIDER TRENDS: Insider Purchase Adds to Odonate Therapeutics Positive Trend
2020ODONATE THERAPEUTICS: Tang Capital Ups Stake in Odonate Therapeutics to 41.6%
2020ODONATE THERAPEUTICS: Insider buy at Odonate Therapeutics (ODT) Extends the Trend of purc..
2020ODONATE THERAPEUTICS: Thinking about buying stock in Gevo Inc, Inovio Pharmaceuticals, Od..
2020INSIDER TRENDS: Insider Buying Continued with Purchase of Odonate Therapeutics Stock
2020ODONATE THERAPEUTICS, INC.(NASDAQGS: ODT) added to NASDAQ Biotechnology Index
2020ODONATE THERAPEUTICS, INC.: Change in Directors or Principal Officers, Financial Statemen..
2020John Lemkey Resigns as Chief Operating Officer of Odonate Therapeutics, Inc
2020ODONATE THERAPEUTICS: Discloses 'Positive' Phase 3 Trial Results for Metastatic Breast Ca..
2020ODONATE THERAPEUTICS, INC.: Other Events, Financial Statements and Exhibits (form 8-K)
2020ODONATE THERAPEUTICS: Announces Positive Results From Phase 3 Trial of Tesetaxel in Metas..
2020ODONATE THERAPEUTICS: Positive Results of CONTESSA, a Phase 3 Study of Tesetaxel in Patie..
2020Odonate Therapeutics, Inc. Announces Positive Results of CONTESSA, a Phase 3 Study of T..
2020ODONATE THERAPEUTICS: Initiates Cohort 3 of CONTESSA TRIO to Evaluate Tesetaxel Monothera..
1  2  3Pross.
Prossimo evento su ODONATE THERAPEUTICS, INC.